Alfredo Fusco, Giuseppe Viglietto, Massimo Santoro
J Clin Invest.
2005;
115(1):20–23
doi:10.1172/JCI23987
This article Copyright © 2005, The American Society for Clinical Investigation
Abstract
|
Full text
|
PDF
I
n this issue of the JCI, Ciampi et al. report the identification of a novel oncogene in patients affected by radiation-associated thyroid papillary carcinomas. This oncogene derives from a paracentric inversion of the long arm of chromosome 7, which results in an in-frame fusion of the N-terminus of the A-kinase anchor protein 9 (AKAP9) gene with the C-terminal catalytic domain (exons 9–18) of the serine-threonine kinase BRAF. The resulting AKAP9-BRAF fusion protein shows constitutive kinase activity, and it is able to transmit mitogenic signals to the MAPK pathways and to promote malignant transformation of NIH3T3 cells.